Haemonetics rises after buying Vivasure in 185 million euro deal

Shares of medical equipment maker Haemonetics HAE.N fall 1.7% to $84.04

Co says it has acquired Ireland-based Vivasure Medical in a deal worth up to 185 million euros ($215 million)

Co says it will pay 100 million euros upfront, and up to 85 million euros tied to completion of certain milestones

Ireland-based Vivasure Medical makes vessel closure devices used after heart and blood vessel procedures - HAE

Vivasure's "PerQseal Elite" patch seals vessels without stitches; approved in Europe, U.S. nod pending - HAE

Co says deal aims to expand it's hospital product portfolio and boost market leadership

As of last close, stock up ~3% over the past year

($1 = 0.8591 euros)